CoChat

Antitumoral Activity of Snake Venom Proteins: New Trends in Cancer Therapy

Open access
Calderon, Leonardo A., Sobrinho, Juliana C., Zaqueo, Kayena D., de Moura, Andrea A., Grabner, Amy N., Mazzi, Maurício V., Marcussi, Silvana, Nomizo, Auro, Fernandes, Carla F. C., Zuliani, Juliana P., Carvalho, Bruna M. A., da Silva, Saulo L., Stábeli, Rodrigo G., Soares, Andreimar M. · 2014 · BioMed Research International
Cited by 228

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

For more than half a century, cytotoxic agents have been investigated as a possible treatment for cancer. Research on animal venoms has revealed their high toxicity on tissues and cell cultures, both normal and tumoral. Snake venoms show the highest cytotoxic potential, since ophidian accidents cause a large amount of tissue damage, suggesting a promising utilization of these venoms or their components as antitumoral agents. Over the last few years, we have studied the effects of snake venoms and their isolated enzymes on tumor cell cultures. Some in vivo assays showed antineoplastic activity against induced tumors in mice. In human beings, both the crude venom and isolated enzymes revealed antitumor activities in preliminary assays, with measurable clinical responses in the advanced treatment phase. These enzymes include metalloproteases (MP), disintegrins, L-amino acid oxidases (LAAOs), C-type lectins, and phospholipases A 2(PLA 2 s). Their mechanisms of action include direct toxic action (PLA 2 s), free radical generation (LAAOs), apoptosis induction (PLA 2 s, MP, and LAAOs), and antiangiogenesis (disintegrins and lectins). Higher cytotoxic and cytostatic activities upon tumor cells than normal cells suggest the possibility for clinical applications. Further studies should be conducted to ensure the efficacy and safety of different snake venom compounds for cancer drug development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2014/203639

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 228

Metadata

Authors
Calderon, L. A., Sobrinho, J. C., Zaqueo, K. D., de Moura, A. A., Grabner, A. N., Mazzi, M. V., Marcussi, S., Nomizo, A., Fernandes, C. F. C., Zuliani, J. P., Carvalho, B. M. A., da Silva, S. L., Stábeli, R. G., & Soares, A. M.
Venue
BioMed Research International
Publisher
Wiley
Published
2014
Volume
2014
Pages
1-19
ISSN
  • 1110-7243 (ISSN-L)
  • 2314-6133
  • 2314-6141
OpenAlex
W2082192485
Cited by
228
References
1
FWCI
12.28
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antitumoral Activity of Snake Venom Proteins: New Trends in Cancer Therapy. https://app.cochat.ai/papers/10.1155/2014/203639
The paper
Calderon, L. A., Sobrinho, J. C., Zaqueo, K. D., de Moura, A. A., Grabner, A. N., Mazzi, M. V., Marcussi, S., Nomizo, A., Fernandes, C. F. C., Zuliani, J. P., Carvalho, B. M. A., da Silva, S. L., Stábeli, R. G., & Soares, A. M. (2014). Antitumoral Activity of Snake Venom Proteins: New Trends in Cancer Therapy. BioMed Research International. https://doi.org/10.1155/2014/203639

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.